Rune Bergman
Directeur Général chez Nordvacc Läkemedel AB
Postes actifs de Rune Bergman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Nordvacc Läkemedel AB
 Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Directeur Général | - | - |
Historique de carrière de Rune Bergman
Anciens postes connus de Rune Bergman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INTERVACC AB | Président | 01/01/2007 | 14/06/2018 |
| Fondateur | 01/01/2001 | 30/06/2019 | |
| Independent Dir/Board Member | 01/01/2001 | - | |
| Sales & Marketing | 01/01/2001 | 30/06/2019 |
Formation de Rune Bergman
| Swedish University of Agricultural Sciences | Doctorate Degree |
Statistiques
Internationale
| Suède | 4 |
Opérationnelle
| Chairman | 1 |
| Founder | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTERVACC AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nordvacc Läkemedel AB
Nordvacc Läkemedel AB Medical DistributorsDistribution Services Part of Intervacc AB, Nordvacc Läkemedel AB is a veterinary pharmaceutical company based in Hägersten, SE. Nordvacc Läkemedel AB was acquired by Sorkaruga AB on March 25, 2014. The Swedish company specializes in the distribution and marketing of veterinary vaccines and medicines for the care and treatment of both companion and farm animals. The company's flagship product, infucal® vet, is a solution for calving paralysis and is vital for the survival of cattle. The product contains calcium, magnesium, a source of phosphorus in the form of sodium hypophosphite, and glucose, which counteracts hypomagnesemia and is used to treat other conditions with hypocalcemia in animals. The CEO of the company is Rune Bergman. | Distribution Services |
- Bourse
- Insiders
- Rune Bergman
- Expérience
